Please note that the following presentation contains financial projections and other forward-looking statements that are specific to the date of the

Size: px
Start display at page:

Download "Please note that the following presentation contains financial projections and other forward-looking statements that are specific to the date of the"

Transcription

1 Please note that the following presentation contains financial projections and other forward-looking statements that are specific to the date of the presentation July 16, 2012 and should not be considered current after that date.

2 Thermo Fisher Scientific to Acquire One Lambda July 16, The world leader in serving science

3 Safe Harbor Statement / Use of Non-GAAP Financial Measures The following constitutes t a "Safe Harbor" statement t t under the Private Securities Litigation Reform Act of 1995: This presentation contains forward-looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in Thermo Fisher's most recent quarterly report, under the caption Risk Factors, which is on file with the Securities and Exchange Commission and available on Thermo Fisher's website. Additional important factors that could cause actual results to differ materially from those indicated by forward-looking statements include risks and uncertainties relating to: the need to develop new products and adapt to significant technological change; implementation of strategies for improving growth; general worldwide economic conditions including economic conditions in the countries in which Thermo Fisher and sell products, and related uncertainties; dependence on customers' capital spending policies and government funding policies; the effect of exchange rate fluctuations on international operations; the effect of healthcare reform legislation; use and protection of intellectual property; p the effect of changes in governmental regulations; and the effect of laws and regulations governing g government contracts, as well as the possibility that expected benefits related to the transaction may not materialize as expected; the transaction not being timely completed, if completed at all; prior to the completion of the transaction, One Lambda s business experiencing disruptions due to transaction-related uncertainty or other factors making it more difficult to maintain relationships with employees, licensees, other business partners or governmental entities; and the parties being unable to successfully implement integration strategies. While Thermo Fisher may elect to update forward-looking statements at some point in the future, Thermo Fisher specifically disclaims i any obligation to do so, even if estimates t change and, therefore, you should not rely on these forward-looking statements as representing our views as of any date subsequent to today. In addition to the financial measures prepared in accordance with generally accepted accounting principles (GAAP), we use certain non-gaap financial a measures, es, including adjusted EPS, adjusted operating income, and adjusted EBITDA, which exclude restructuring and other costs/income and amortization of acquisition-related intangible assets. Adjusted EPS also excludes certain other gains and losses, tax provisions/benefits related to the previous items, benefits from tax credit carryforwards, the impact of significant tax audits or events and discontinued operations. We exclude the above items because they are outside of our normal operations and/or, in certain cases, are difficult to forecast accurately for future periods. We believe that the use of non- GAAP measures helps investors to gain a better understanding of our core operating results and future prospects, consistent with how management measures and forecasts the company's performance, especially when comparing such results to previous periods or forecasts. 2

4 One Lambda Creating Shareholder Value One Lambda the global leader in transplant diagnostics Consistent with our specialty in vitro diagnostics strategy Complements our immunosuppressant drug monitoring product offering Creates opportunity to leverage commercial infrastructure in emerging markets $925 million purchase price funded with cash and new debt Financially compelling Immediately accretive, solid return, attractive valuation Expected to close in Q4 of 2012 Customary regulatory approvals Further enhances our leadership in specialty diagnostics 3

5 One Lambda The Clear Global Leader in Transplant Diagnostics Serology 7% 2011 Revenue World leader in transplant diagnostics 2011 revenue: $182 million HLA Typing 44% Antibody Detection 49% 1,400 customers Transplant centers HLA clinical, academic and research testing labs Clinicians Headquartered in Canoga Park, California 320 employees Asia Pacific 5% Brazil 10% ROW 5% Europe 21% North America 59% 4

6 Transplant Diagnostics is an Attractive Market $480 million market in 2011, growing mid- to high-single digits Growth of transplant diagnostics market driven by: Increasing global demand for transplant procedures Increasing utilization (i.e., tests per patient) Growing use of post-transplant antibody monitoring i due to new scientific ifi evidence showing continued antibody monitoring improves graft survival New drug therapy enables a compelling companion diagnostics opportunity Transplant Testing Workflow Cross- HLA Typing Screening Identification Transplant Matching Post-Transplant Monitoring One Lambda is the leader in transplant diagnostics 5 Source: Scientia Advisors Analysis

7 Increases Our Depth of Capabilities in Specialty Diagnostics Thermo Fisher Specialty Diagnostics Segment Healthcare Market Channel Anatomical Pathology Microbiology Clinical Assays One Lambda Immunodiagnostics Strong Strategic Fit Markets Expands presence in attractive and growing market segment Opportunity to leverage Thermo Fisher s strength in emerging markets Technologies Enhances Thermo Fisher offering in immune-response diagnostics space Customers Leverage One Lambda s deep, longstanding customer relationships Pro Forma Revenues* $3.0B 6 * Revenues based on LTM ending 3/31/12

8 Significant Financial Benefits Create Shareholder Value Expected to be immediately accretive to adjusted EPS and add approximately $0.09 -$0.11 in 2013 Synergies Expect total t adjusted d operating income benefit of approximately $15 million in 2015 Net of approximately $10 million of incremental investments to improve operating processes and fund development Opportunity to leverage Thermo Fisher s global infrastructure and commercial presence to accelerate growth Tax efficiencies from leveraging Thermo Fisher s global structure 338(h)(10) election to provide significant cash tax benefit Creates annual cash tax savings of approximately $19 million for 15 years, resulting in $190 million NPV tax benefit Attractive purchase price multiple Implied 2011 EBITDA purchase price multiple of 10.9x Including value of 338(h)(10) tax benefit, implied 2011 EBITDA purchase price multiple of 8.7x Transaction ROIC expected to exceed WACC in

9 Consistently Returning Capital to Our Shareholders Share Repurchase Program Board of Directors authorized an additional $500 million share repurchase program effective 7/15/12 expires 12/31/12 $250 million remaining of existing $750 million repurchase authorization $400 million spent in first half of 2012 and $100 million in Q Total of $750 million available for the remainder of 2012 Dividend Board of Directors authorized first dividend in early 2012 Initial quarterly dividend of $0.13 paid April 16 Subsequent dividends of $0.13 payable July 15, October 15 8

10 One Lambda Creating Shareholder Value Very well aligned with our specialty diagnostics strategy Further enhances our leadership in specialty diagnostics Financially compelling transaction 9

Please note that the following presentation contains financial projections and other forward-looking statements that are specific to the date of the

Please note that the following presentation contains financial projections and other forward-looking statements that are specific to the date of the Please note that the following presentation contains financial projections and other forward-looking statements that are specific to the date of the presentation January 13, 2015 and should not be considered

More information

july 2012 CEB to Acquire SHL Compelling Value Creation, Growth, and Scale Opportunity

july 2012 CEB to Acquire SHL Compelling Value Creation, Growth, and Scale Opportunity july 2012 CEB to Acquire SHL Compelling Value Creation, Growth, and Scale Opportunity Safe Harbor Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities

More information

GAAP/Non-GAAP Reconciliation and Financial Package October 27, 2016

GAAP/Non-GAAP Reconciliation and Financial Package October 27, 2016 GAAP/Non-GAAP Reconciliation and Financial Package October 27, 2016 The World Leader in Serving Science Use of Non-GAAP Financial Measures In addition to the financial measures prepared in accordance with

More information

WILLIAM BLAIR GROWTH STOCK CONFERENCE JUNE 12, 2018 CHICAGO, IL

WILLIAM BLAIR GROWTH STOCK CONFERENCE JUNE 12, 2018 CHICAGO, IL WILLIAM BLAIR GROWTH STOCK CONFERENCE JUNE 12, 2018 CHICAGO, IL FORWARD LOOKING STATEMENT AND USE OF ADJUSTED MEASURES This presentation contains forward-looking statements including but not limited to

More information

SYNNEX Concentrix Division Announces the Acquisition of Convergys

SYNNEX Concentrix Division Announces the Acquisition of Convergys Filed by SYNNEX Corporation pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company:

More information

UBS Healthcare Conference John J. Greisch, President and CEO. May 22, 2017

UBS Healthcare Conference John J. Greisch, President and CEO. May 22, 2017 UBS Healthcare Conference John J. Greisch, President and CEO May 22, 2017 Forward Looking Statements This presentation contains forward-looking statements, within the meaning of the Private Securities

More information

GAAP/Non-GAAP Reconciliation and Financial Package February 28, 2018

GAAP/Non-GAAP Reconciliation and Financial Package February 28, 2018 The Balance Sheet on page 10 of this document has been updated from the version published on January 31, 2018 to reflect final numbers as published in the Thermo Fisher Scientific Inc. Form 10-K for the

More information

Diplomat s Acquisition of LDI Integrated Pharmacy Services. Nov. 15, 2017

Diplomat s Acquisition of LDI Integrated Pharmacy Services. Nov. 15, 2017 Diplomat s Acquisition of LDI Integrated Pharmacy Services Nov. 15, 2017 1 DISCLAIMERS NON-GAAP INFORMATION We define Adjusted EBITDA as net income (loss) before interest expense, income taxes, depreciation

More information

Xylem Agrees to Acquire Sensus to Broaden Portfolio and Enhance Growth Platform AUGUST 15, 2016

Xylem Agrees to Acquire Sensus to Broaden Portfolio and Enhance Growth Platform AUGUST 15, 2016 1 Xylem Agrees to Acquire Sensus to Broaden Portfolio and Enhance Growth Platform AUGUST 15, 2016 Forward-Looking Statements This presentation contains information that may constitute forward-looking statements.

More information

+ September 12, 2017

+ September 12, 2017 + September 12, 2017 Safe Harbor Statement CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS This document contains certain forward-looking statements with respect to the financial condition, results

More information

Acquisition of Dealer Inspire and Launch Digital Marketing

Acquisition of Dealer Inspire and Launch Digital Marketing Acquisition of Dealer Inspire and Launch Digital Marketing Investor Presentation February 14, 2018 Forward Looking Statements This presentation contains forward looking statements within the meaning of

More information

GAAP/Non-GAAP Reconciliation and Financial Package

GAAP/Non-GAAP Reconciliation and Financial Package GAAP/Non-GAAP Reconciliation and Financial Package April 25, 2018 The world leader in serving science Use of Non-GAAP Financial Measures In addition to the financial measures prepared in accordance with

More information

Hill-Rom Fourth Quarter 2016 Financial Results. November 3, 2016

Hill-Rom Fourth Quarter 2016 Financial Results. November 3, 2016 Hill-Rom Fourth Quarter 2016 Financial Results November 3, 2016 Forward Looking Statements Certain statements in this presentation contain forward-looking statements, within the meaning of the Private

More information

ESI Announcement 10/30/2018

ESI Announcement 10/30/2018 ESI Announcement 10/30/2018 Safe Harbor for Forward Looking Statements Statements in this presentation regarding the proposed transaction between MKS Instruments, Inc. ( MKS ) and Electro Scientific Industries

More information

GSI Group to Acquire NDS Surgical Imaging for $82.5 Million

GSI Group to Acquire NDS Surgical Imaging for $82.5 Million FOR IMMEDIATE RELEASE January 15, 2013 GSI Group to Acquire NDS Surgical Imaging for $82.5 Million NDS is the leading producer of high performance visualization products sold to OEMs in the surgical endoscopy

More information

A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers

A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers Baird Healthcare Conference, September 2017 NASDAQ: NOVT 1 Safe Harbor Statement The statements in this presentation

More information

Zimmer Biomet Reports Second Quarter 2016 Financial Results

Zimmer Biomet Reports Second Quarter 2016 Financial Results July 28, 2016 Zimmer Biomet Reports Second Quarter 2016 Financial Results -- Net Sales of $1.934 billion represent an increase of 65.6% over the prior year period, and an increase of 4.5% on an adjusted

More information

GAAP/Non-GAAP Reconciliation and Financial Package

GAAP/Non-GAAP Reconciliation and Financial Package GAAP/Non-GAAP Reconciliation and Financial Package January 8, 2018 The world leader in serving science Use of Non-GAAP Financial Measures In addition to the financial measures prepared in accordance with

More information

Energizer to Acquire Spectrum Brands Global Battery and Portable Lighting Business. January 16, 2018

Energizer to Acquire Spectrum Brands Global Battery and Portable Lighting Business. January 16, 2018 Energizer to Acquire Spectrum Brands Global Battery and Portable Lighting Business January 16, 2018 Safe Harbor Statement Unless the context otherwise requires, references in this presentation to Energizer,

More information

PolyOne Investor Presentation Credit Suisse Boston Basic Materials Conference. June 26, 2013

PolyOne Investor Presentation Credit Suisse Boston Basic Materials Conference. June 26, 2013 PolyOne Investor Presentation Credit Suisse Boston Basic Materials Conference June 26, 2013 Forward Looking Statements In this presentation, statements that are not reported financial results or other

More information

LPL Financial. Purchase of National Planning Holdings, Inc. August 15, Member FINRA/SIPC

LPL Financial. Purchase of National Planning Holdings, Inc. August 15, Member FINRA/SIPC LPL Financial Purchase of National Planning Holdings, Inc. August 15, 2017 Member FINRA/SIPC Notice to Investors: Safe Harbor Statement Statements in this presentation regarding LPL Financial Holdings

More information

LOOKING statements. Forward

LOOKING statements. Forward 1 Forward LOOKING statements This presentation contains forward-looking statements regarding future events or the future financial performance of the Company that involve substantial risks and uncertainties.

More information

IDEXX Laboratories Announces Third Quarter Results

IDEXX Laboratories Announces Third Quarter Results FOR IMMEDIATE RELEASE Contact: Kerry Bennett, Investor Relations, 1-207-556-8155 IDEXX Laboratories Announces Third Quarter Results Reports revenue growth of 11% on a reported basis and 12% on an organic

More information

United Rentals to Acquire RSC Holdings

United Rentals to Acquire RSC Holdings United Rentals to Acquire RSC Holdings Investor Presentation DECEMBER 2011 Introductory Information Cautionary Statement Regarding Forward-Looking Statements This document contains forward-looking statements

More information

Magellan Health. Cantor Fitzgerald Healthcare Conference September 26, 2017

Magellan Health. Cantor Fitzgerald Healthcare Conference September 26, 2017 Magellan Health Cantor Fitzgerald Healthcare Conference September 26, 2017 Cautionary Statement and Non-GAAP measures 2 This slide presentation and our accompanying oral comments include forward-looking

More information

William Blair 35 th Annual Growth Stock Conference. June 9, 2015 NYSE: Q. Copyright 2014 Quintiles

William Blair 35 th Annual Growth Stock Conference. June 9, 2015 NYSE: Q. Copyright 2014 Quintiles William Blair 35 th Annual Growth Stock Conference June 9, 2015 Copyright 2014 Quintiles NYSE: Q Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking

More information

News from Aon Aon Reports Fourth Quarter and Full Year 2018 Results Fourth Quarter Key Metrics as Reported Under U.S. GAAP(1)

News from Aon Aon Reports Fourth Quarter and Full Year 2018 Results Fourth Quarter Key Metrics as Reported Under U.S. GAAP(1) Investor Relations News from Aon Aon Reports Fourth Quarter and Full Year Results Fourth Quarter Key Metrics as Reported Under U.S. GAAP (1) Total revenue decreased 5 to $2.8 billion, including a decrease

More information

Acquisition Offer of RPC Group PLC

Acquisition Offer of RPC Group PLC Always Advancing To Protect What s Important Acquisition Offer of RPC Group PLC March 2019 NYSE: BERY Safe Harbor Statements THIS PRESENTATION AND ITS CONTENTS ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION,

More information

June 8, Acquisitions Update Call

June 8, Acquisitions Update Call June 8, 2018 Acquisitions Update Call Certain statements contained in this presentation that are not historical facts, including any statements as to future market conditions, results of operations, and

More information

Combination Creates Leading Innovator in the Musculoskeletal Industry April 24, 2014

Combination Creates Leading Innovator in the Musculoskeletal Industry April 24, 2014 Combination Creates Leading Innovator in the Musculoskeletal Industry April 24, 2014 David Dvorak President and Chief Executive Officer Jim Crines EVP, Finance, and Chief Financial Officer Cautionary Statement

More information

IDEXX Laboratories Announces Second Quarter Results

IDEXX Laboratories Announces Second Quarter Results FOR IMMEDIATE RELEASE Contact: Ed Garber, Director, Investor Relations, 1-207-556-8155 IDEXX Laboratories Announces Second Quarter Results Delivers 9% organic revenue growth and $1.10 EPS, driven by double-digit

More information

Ingersoll Rand s Acquisition of Precision Flow Systems (PFS) February 11, 2019

Ingersoll Rand s Acquisition of Precision Flow Systems (PFS) February 11, 2019 Ingersoll Rand s Acquisition of Precision Flow Systems (PFS) February 11, 2019 1 Safe Harbor This presentation contains forward-looking statements, which are statements that are not historical facts, including

More information

Earnings Presentation October 25, 2018

Earnings Presentation October 25, 2018 nvent Third Quarter 2018 Earnings Presentation October 25, 2018 Forward-Looking Statement CAUTION CONCERNING FORWARD-LOOKING STATEMENTS This presentation contains statements that we believe to be "forward-looking

More information

Innovation with Integrity. Bruker Corporation

Innovation with Integrity. Bruker Corporation Bruker drives profitable growth and margin expansion by enabling scientific discoveries and by delivering highperformance analytical, life science and diagnostic solutions Bruker Corporation Innovation

More information

PolyOne Investor Presentation KeyBanc 2014 Basic Materials & Packaging Conference Boston, MA September 10, 2014

PolyOne Investor Presentation KeyBanc 2014 Basic Materials & Packaging Conference Boston, MA September 10, 2014 PolyOne Investor Presentation KeyBanc 2014 Basic Materials & Packaging Conference Boston, MA September 10, 2014 PolyOne Corporation Page 1 Forward-Looking Statements In this presentation, statements that

More information

IDEXX Laboratories Announces First Quarter Results

IDEXX Laboratories Announces First Quarter Results FOR IMMEDIATE RELEASE Contact: Merilee Raines, Chief Financial Officer, 1-207-556-8155 IDEXX Laboratories Announces First Quarter Results WESTBROOK, Maine, IDEXX Laboratories, Inc. (NASDAQ: IDXX), today

More information

Acquisition of Astra Tech June 22, 2011 NASDAQ-XRAY

Acquisition of Astra Tech June 22, 2011 NASDAQ-XRAY Acquisition of Astra Tech June 22, 2011 1 Forward Looking Statements This presentation, in addition to historical information, contains forward-looking statements (as defined in the Securities Litigation

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K. Aon plc (Exact Name of Registrant as Specified in Charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K. Aon plc (Exact Name of Registrant as Specified in Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event

More information

2018 SECOND QUARTER FINANCIAL RESULTS

2018 SECOND QUARTER FINANCIAL RESULTS 2018 SECOND QUARTER FINANCIAL RESULTS July 30, 2018 0 SAFE HARBOR STATEMENT The 2018 second quarter news release, conference call webcast, and the following slides contain forward-looking statements. The

More information

News from Aon Aon Reports Fourth Quarter and Full Year 2017 Results Fourth Quarter Key Metrics From Continuing Operations and Highlights

News from Aon Aon Reports Fourth Quarter and Full Year 2017 Results Fourth Quarter Key Metrics From Continuing Operations and Highlights Investor Relations News from Aon Aon Reports Fourth Quarter and Full Year Results Fourth Quarter Key Metrics From Continuing Operations and Highlights Reported revenue increased 10 to $2.9 billion with

More information

Bruker Corporation (NASDAQ: BRKR)

Bruker Corporation (NASDAQ: BRKR) Bruker Corporation (NASDAQ: BRKR) Q4 2017 Earnings Presentation February 8, 2018 Frank Laukien, President & CEO Anthony Mattacchione, SVP & CFO Miroslava Minkova, Head of Investor Relations Innovation

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K. Aon plc (Exact Name of Registrant as Specified in Charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K. Aon plc (Exact Name of Registrant as Specified in Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event

More information

GAAP/Non-GAAP Reconciliation and Financial Package

GAAP/Non-GAAP Reconciliation and Financial Package GAAP/Non-GAAP Reconciliation and Financial Package October 24, 2018 The world leader in serving science Use of Non-GAAP Financial Measures In addition to the financial measures prepared in accordance with

More information

Fiserv Investor Conference Call. January 14, 2013

Fiserv Investor Conference Call. January 14, 2013 Fiserv Investor Conference Call January 14, 2013 Forward-Looking Statements and Non-GAAP Financial Information The information disclosed in this presentation contains forward-looking statements, including

More information

The Hartford Financial Services Group, Inc. December 2017 Overview of The Hartford

The Hartford Financial Services Group, Inc. December 2017 Overview of The Hartford The Hartford Financial Services Group, Inc. December 2017 Overview of The Hartford Copyright 2017 by The Hartford. All rights reserved. No part of this document may be reproduced, published or posted without

More information

MSCI. Raymond James 38 th Annual Institutional Investors Conference. Kathleen Winters, CFO. March 8, 2017

MSCI. Raymond James 38 th Annual Institutional Investors Conference. Kathleen Winters, CFO. March 8, 2017 MSCI Raymond James 38 th Annual Institutional Investors Conference Kathleen Winters, CFO March 8, 2017 2017 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. FORWARD

More information

Reports Strong Net New Bookings and Recurring Revenue for Fiscal Year 2017

Reports Strong Net New Bookings and Recurring Revenue for Fiscal Year 2017 Press Release Nuance Announces Fourth Quarter and Fiscal Year 2017 Results Reports Strong Net New Bookings and Recurring Revenue for Fiscal Year 2017 BURLINGTON, Mass., (NASDAQ: NUAN) today announced financial

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event

More information

IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter)

IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event

More information

Aon plc. First Quarter 2017 Results May 9, 2017

Aon plc. First Quarter 2017 Results May 9, 2017 Aon plc First Quarter 2017 Results May 9, 2017 Greg Case Chief Executive Officer Christa Davies Chief Financial Officer 1 Safe Harbor Statement This communication contain certain statements related to

More information

Raymond James 37 th Annual Institutional Investors Conference. March 8, 2016

Raymond James 37 th Annual Institutional Investors Conference. March 8, 2016 Raymond James 37 th Annual Institutional Investors Conference March 8, 2016 Forward-looking statements and Non-GAAP financial measures Forward-looking statements Certain statements included in this presentation,

More information

Zebra Technologies Second-Quarter 2018 Results. August 7, 2018

Zebra Technologies Second-Quarter 2018 Results. August 7, 2018 Zebra Technologies Second-Quarter 2018 Results August 7, 2018 Safe Harbor Statement Statements made in this presentation which are not statements of historical fact are forward-looking statements and are

More information

First Quarter 2018 Financial Results. January 26, 2018

First Quarter 2018 Financial Results. January 26, 2018 First Quarter 2018 Financial Results January 26, 2018 This presentation contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. All statements included

More information

INVESTOR PRESENTATION MAY 2017

INVESTOR PRESENTATION MAY 2017 INVESTOR PRESENTATION MAY 2017 FORWARD-LOOKING STATEMENTS AND NON-GAAP FINANCIAL INFORMATION Forward-Looking Statements Certain statements and information in this communication may be deemed to be forward-looking

More information

Jarden Investor Presentation. October 14, 2015

Jarden Investor Presentation. October 14, 2015 Jarden Investor Presentation October 14, 2015 Cautionary Statement Please note that in this presentation, we may discuss events or results that have not yet occurred or been realized, commonly referred

More information

Investor Presentation. February 2018

Investor Presentation. February 2018 Investor Presentation February 2018 1 Forward Looking Statements Important Information About Littelfuse, Inc. This presentation does not constitute or form part of, and should not be construed as, an offer

More information

Dave Carlucci Chairman and CEO IMS Health

Dave Carlucci Chairman and CEO IMS Health Dave Carlucci Chairman and CEO IMS Health 1 March 11, 2009 Safe Harbor Certain statements we make today are forward-looking within the meaning of the US federal securities laws. These statements include,

More information

IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter)

IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event

More information

Myriad Genetics Reports Fiscal Third-Quarter 2018 Financial Results

Myriad Genetics Reports Fiscal Third-Quarter 2018 Financial Results May 8, 2018 Myriad Genetics Reports Fiscal Third-Quarter 2018 Financial Results Total Revenues of $193.5 Million GAAP Diluted EPS of $0.16 and Adjusted EPS of $0.31 Up 15 Percent Company Raises Both Revenue

More information

LABCORP ANNOUNCES 2018 SECOND QUARTER RESULTS AND UPDATES 2018 GUIDANCE

LABCORP ANNOUNCES 2018 SECOND QUARTER RESULTS AND UPDATES 2018 GUIDANCE FOR IMMEDIATE RELEASE Contact: Scott Frommer (investors) 336-436-5076 Investor@labcorp.com Pattie Kushner (media) 336-436-8263 Media@labcorp.com LABCORP ANNOUNCES 2018 SECOND QUARTER RESULTS AND UPDATES

More information

June Dear Fellow Takeda Shareholder,

June Dear Fellow Takeda Shareholder, June 2018 Dear Fellow Takeda Shareholder, Since joining Takeda in April 2014, my mission has been to continue the transformation of Takeda in order to ensure that Takeda will be a successful company in

More information

Staples, Inc. Details Corporate Express Integration Plans and Announces Preliminary Second Quarter Performance

Staples, Inc. Details Corporate Express Integration Plans and Announces Preliminary Second Quarter Performance Media Contact: Investor Contact: Paul Capelli/Owen Davis 508-253-8530/8468 Laurel Lefebvre/Chris Powers 508-253-4080/4632 Staples, Inc. Details Corporate Express Integration Plans and Announces Preliminary

More information

Allscripts Healthcare Solutions

Allscripts Healthcare Solutions Allscripts Healthcare Solutions J A N U A R Y 2 0 1 9 J.P. Morgan Healthcare Conference Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation

More information

Amcor & Bemis Combination Creating the Global Leader in Consumer Packaging. 6 August 2018

Amcor & Bemis Combination Creating the Global Leader in Consumer Packaging. 6 August 2018 Amcor & Bemis Combination Creating the Global Leader in Consumer Packaging 6 August 2018 Disclaimer Cautionary Statement Regarding Forward-Looking Statements This communication contains certain statements

More information

The Hartford Financial Services Group, Inc. November 2017 Overview of The Hartford

The Hartford Financial Services Group, Inc. November 2017 Overview of The Hartford The Hartford Financial Services Group, Inc. November 2017 Overview of The Hartford Copyright 2017 by The Hartford. All rights reserved. No part of this document may be reproduced, published or posted without

More information

ZEBRA TECHNOLOGIES SECOND-QUARTER 2016 RESULTS. August 9, 2016

ZEBRA TECHNOLOGIES SECOND-QUARTER 2016 RESULTS. August 9, 2016 ZEBRA TECHNOLOGIES SECOND-QUARTER 2016 RESULTS August 9, 2016 Anders Gustafsson Chief Executive Officer Mike Smiley Chief Financial Officer 2 Safe Harbor Statement Statements made in this presentation

More information

Capturing the Opportunity

Capturing the Opportunity Capturing the Opportunity JANUARY 2018 BETHANY DIPLOMAT PATIENT Copyright 2018 by Diplomat Pharmacy Inc. Diplomat is a registered trademark of Diplomat Pharmacy Inc. All rights reserved. 1 SPECIALTY DRUGS

More information

Compelling Strategic Transaction

Compelling Strategic Transaction ACQUISITION OF DJO GLOBAL November 19, 2018 Forward Looking Statements & Non-GAAP Disclaimer The following information may contain forward-looking statements, including forward-looking statements within

More information

InfuSystem Holdings, Inc. (Exact name of registrant as specified in its charter)

InfuSystem Holdings, Inc. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

IDEXX Laboratories Announces First Quarter Results

IDEXX Laboratories Announces First Quarter Results FOR IMMEDIATE RELEASE Contact: Kerry Bennett, Investor Relations, 1-207-556-8155 IDEXX Laboratories Announces First Quarter Results Reports revenue growth of 11% on both a reported and organic basis, driven

More information

Safe Harbor Statement

Safe Harbor Statement January 3, 2018 Safe Harbor Statement Statements in this presentation that are not historical, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation

More information

Mylan Reports Third Quarter 2017 Results and Updates 2017 Guidance

Mylan Reports Third Quarter 2017 Results and Updates 2017 Guidance November 6, Mylan Reports Third Quarter Results and Updates Guidance HERTFORDSHIRE, England and PITTSBURGH, Nov. 6, /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced its financial results

More information

DMS Health Technologies, Inc. ACQUISITION OVERVIEW OCTOBER 14, 2015

DMS Health Technologies, Inc. ACQUISITION OVERVIEW OCTOBER 14, 2015 DMS Health Technologies, Inc. ACQUISITION OVERVIEW OCTOBER 14, 2015 FORWARD-LOOKING STATEMENTS Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The presentation and information

More information

A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers

A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers Baird Industrial Conference, November 2017 Matthijs Glastra, Chief Executive Officer NASDAQ: NOVT 1 Safe Harbor Statement

More information

Second Quarter 2017 Reconciliation of Non-GAAP Financial Measures

Second Quarter 2017 Reconciliation of Non-GAAP Financial Measures Second Quarter 2017 Reconciliation of Non-GAAP Financial Measures Adjusted Operating Income Reconciliation Adjusted operating income is not a measure of financial performance under generally accepted accounting

More information

Avery Dennison. Baird 2018 Global Industrial Conference. Mitch Butier President and Chief Executive Officer. November 8, 2018

Avery Dennison. Baird 2018 Global Industrial Conference. Mitch Butier President and Chief Executive Officer. November 8, 2018 Avery Dennison November 8, 2018 Mitch Butier President and Chief Executive Officer 1 Forward-Looking Statements Certain statements contained in this document are "forward-looking statements" intended to

More information

ESTABLISHING A GLOBAL LEADER IN WORKWEAR 1. August 14, 2017

ESTABLISHING A GLOBAL LEADER IN WORKWEAR 1. August 14, 2017 ESTABLISHING A GLOBAL LEADER IN WORKWEAR 1 August 14, 2017 FORWARD-LOOKING STATEMENTS Certain statements included in this presentation are "forward-looking statements" within the meaning of the federal

More information

Investor Presentation June 18, 2014 TE CONNECTIVITY ACQUIRES MEASUREMENT SPECIALTIES

Investor Presentation June 18, 2014 TE CONNECTIVITY ACQUIRES MEASUREMENT SPECIALTIES Investor Presentation June 18, 2014 TE CONNECTIVITY ACQUIRES MEASUREMENT SPECIALTIES Forward-Looking Statements Forward Looking Statements This presentation contains certain forward-looking statements

More information

Aon Reports First Quarter 2018 Results

Aon Reports First Quarter 2018 Results Investor Relations News from Aon Aon Reports First Quarter 2018 Results First Quarter Key Metrics as Reported under U.S. GAAP (1) Total revenue increased 30% to $3.1 billion, including an increase of $365

More information

FOR IMMEDIATE RELEASE

FOR IMMEDIATE RELEASE Company Investor/Media Contact: DJO Incorporated Mark Francois, Director of Investor Relations (760) 734-4766 mark.francois@djoglobal.com FOR IMMEDIATE RELEASE DJO INCORPORATED ANNOUNCES FINANCIAL RESULTS

More information

DANAHER TO ACQUIRE GE LIFE SCIENCES BIOPHARMA BUSINESS ( GE Biopharma ) February 25, 2019

DANAHER TO ACQUIRE GE LIFE SCIENCES BIOPHARMA BUSINESS ( GE Biopharma ) February 25, 2019 DANAHER TO ACQUIRE GE LIFE SCIENCES BIOPHARMA BUSINESS ( GE Biopharma ) February 25, 2019 Forward Looking Statements Statements in this presentation and the accompanying call that are not strictly historical,

More information

A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers

A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers February 2018 Matthijs Glastra, Chief Executive Officer NASDAQ: NOVT 1 Safe Harbor Statement The statements in this

More information

22 nd Annual Credit Suisse Healthcare Conference. November 12, nd Annual Credit Suisse Healthcare Conference November 12, 2013.

22 nd Annual Credit Suisse Healthcare Conference. November 12, nd Annual Credit Suisse Healthcare Conference November 12, 2013. 22 nd Annual Credit Suisse Healthcare Conference November 12, 2013 1 Safe Harbor For Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of

More information

Fiserv to Combine with First Data to Create Global Leader in Payments and FinTech

Fiserv to Combine with First Data to Create Global Leader in Payments and FinTech Fiserv to Combine with First Data to Create Global Leader in Payments and FinTech Investor Presentation January 6, 209 Forward Looking Statements The information disclosed in this presentation contains

More information

Gabelli Pump, Valve and Water Systems Symposium

Gabelli Pump, Valve and Water Systems Symposium Advanced Flow Solutions Energy Pumping Technologies Gabelli Pump, Valve and Water Systems Symposium Scott Buckhout President & CEO 1 February 22, 2018 1 Safe Harbor This presentation contains forward-looking

More information

Dunbar Acquisition Strengthening Our U.S. Operations

Dunbar Acquisition Strengthening Our U.S. Operations Dunbar Acquisition Strengthening Our U.S. Operations MAY 31, 2018 Safe Harbor Statement and Non-GAAP Results These materials contain forward-looking information. Words such as "anticipate," "assume," "estimate,"

More information

Forward-Looking Statements

Forward-Looking Statements William Blair & Company 27 th Annual Growth Stock Conference June 20, 2007 0 Forward-Looking Statements This presentation contains forward-looking statements that are subject to a number of risks and uncertainties,

More information

SS&C Technologies (NASDAQ:SSNC)

SS&C Technologies (NASDAQ:SSNC) SS&C Technologies (NASDAQ:SSNC) Leading Software Provider to the Institutional, Alternative and Wealth Management Markets SS&C to Acquire DST Systems January 11, 2018 Safe Harbor Statement Safe Harbor

More information

Investor Relations Hologic

Investor Relations Hologic Investor Relations Hologic Hologic Announces Financial Results for Second Quarter of Fiscal 2017 -- GAAP Diluted EPS of $1.84 Increases 666.7%, Non-GAAP Diluted EPS of $0.50 Increases 6.4% -- -- Revenue

More information

Ecolab Acquisition of Champion

Ecolab Acquisition of Champion Ecolab Acquisition of Champion Strengthening opportunities and positions in the fast-growing energy services markets October 12, 2012 1 Cautionary Statement Cautionary Statements Regarding Forward-Looking

More information

Myriad Genetics Reports Fiscal Fourth-Quarter 2017 and Fiscal Full-Year 2017 Financial Results

Myriad Genetics Reports Fiscal Fourth-Quarter 2017 and Fiscal Full-Year 2017 Financial Results August 8, 2017 Myriad Genetics Reports Fiscal Fourth-Quarter 2017 and Fiscal Full-Year 2017 Financial Results Total Revenues of $200.5 Million Up 8 Percent GAAP Diluted EPS was $0.19 and Adjusted EPS of

More information

United Rentals to Acquire NES Rentals

United Rentals to Acquire NES Rentals United Rentals to Acquire NES Rentals Investor Presentation January 25, 2017 Introductory Information This presentation contains forward-looking statements within the meaning of Section 21E of the Securities

More information

First Quarter 2017 Earnings Call Presentation. April 26, 2017

First Quarter 2017 Earnings Call Presentation. April 26, 2017 First Quarter 2017 Earnings Call Presentation April 26, 2017 1 Forward-Looking Statements / Safe Harbor This presentation contains forward-looking statements, including statements regarding the proposed

More information

Gartner to Acquire CEB for $2.6 Billion in Cash and Stock

Gartner to Acquire CEB for $2.6 Billion in Cash and Stock Gartner to Acquire CEB for $2.6 Billion in Cash and Stock Creates the Leading Global Research and Advisory Company for All Major Functions in the Enterprise Gartner s Proven Operational Expertise and Sustained

More information

J.P. Morgan Healthcare Conference

J.P. Morgan Healthcare Conference J.P. Morgan Healthcare Conference John J. Greisch, President and CEO January 9, 2018 This presentation contains forward-looking statements, within the meaning of the Private Securities Litigation Reform

More information

Acquisition of PARAGARD IUD from Teva September 11, 2017

Acquisition of PARAGARD IUD from Teva September 11, 2017 Acquisition of PARAGARD IUD from Teva Forward Looking Statements Forward Looking Statements This earnings release contains "forward looking statements" as defined by the Private Securities Litigation Reform

More information

DANAHER CORPORATION Second Quarter 2018 Earnings Release. July 19, 2018

DANAHER CORPORATION Second Quarter 2018 Earnings Release. July 19, 2018 DANAHER CORPORATION Second Quarter 2018 Earnings Release July 19, 2018 Forward Looking Statements Statements in this presentation that are not strictly historical, including any statements regarding the

More information

4Q 2017 Presentation. February 27, 2018

4Q 2017 Presentation. February 27, 2018 4Q 2017 Presentation February 27, 2018 SAFE HARBOR Statements contained in this presentation that are not historical and reflect our views about future periods and events, including our future performance,

More information

Investor Presentation

Investor Presentation Investor Presentation J.P. Morgan 36 th Annual Healthcare Conference San Francisco, CA January 2018 Forward-Looking Statements This presentation contains forward-looking statements (as defined in the Securities

More information